Summit Financial LLC lessened its stake in Danaher Co. (NYSE:DHR – Free Report) by 1.2% during the fourth quarter, HoldingsChannel reports. The firm owned 8,278 shares of the conglomerate’s stock after selling 98 shares during the period. Summit Financial LLC’s holdings in Danaher were worth $1,902,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also bought and sold shares of the company. Heck Capital Advisors LLC bought a new stake in shares of Danaher in the fourth quarter valued at $27,000. Decker Retirement Planning Inc. purchased a new stake in Danaher in the 4th quarter worth about $31,000. Golden State Wealth Management LLC bought a new stake in Danaher in the 4th quarter valued at about $31,000. Pineridge Advisors LLC boosted its position in Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 57 shares during the period. Finally, Rialto Wealth Management LLC purchased a new position in shares of Danaher in the fourth quarter worth about $34,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Analyst Upgrades and Downgrades
DHR has been the topic of a number of recent research reports. JPMorgan Chase & Co. dropped their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Citigroup cut their price target on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a report on Thursday, January 30th. The Goldman Sachs Group upgraded Danaher from a “neutral” rating to a “buy” rating and set a $260.00 price objective on the stock in a research note on Friday, March 21st. Wells Fargo & Company cut their target price on Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Finally, Stifel Nicolaus upgraded Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target on the stock in a research report on Friday, March 14th. Five research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $278.24.
Insider Buying and Selling
In other news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 11.10% of the stock is owned by corporate insiders.
Danaher Trading Down 2.4 %
Shares of DHR stock opened at $200.09 on Wednesday. The business has a 50-day moving average price of $213.02 and a two-hundred day moving average price of $235.39. Danaher Co. has a 12-month low of $196.80 and a 12-month high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The firm has a market cap of $143.01 billion, a P/E ratio of 37.90, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the business posted $2.09 earnings per share. Equities analysts anticipate that Danaher Co. will post 7.63 EPS for the current fiscal year.
Danaher Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 annualized dividend and a dividend yield of 0.64%. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is currently 24.24%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- What Investors Need to Know to Beat the Market
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- 10 Best Airline Stocks to Buy
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- Dividend Payout Ratio Calculator
- Buffett Trims Equities, But Still Keeps Buying This Stock
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.